Literature DB >> 12027980

Effect of venous ulcer exudates on angiogenesis in vitro.

S L Drinkwater1, A Smith, B M Sawyer, K G Burnand.   

Abstract

BACKGROUND: Angiogenesis, the formation of new from existing capillaries, is an important mechanism in venous ulcer healing. The aim of this study was to determine whether venous leg ulcer wound exudates stimulate or inhibit angiogenesis.
METHODS: Fluid exudate was obtained from 16 venous ulcers over a 4-h interval. Five of the ulcers had not healed after more than 1 year of compression bandaging, and five were rapidly healing ulcers. As a control, acute wound fluids were collected from subcutaneous drains in seven patients. Vascular endothelial growth factor (VEGF) at 2 ng/ml acted as a positive control. Tubules stained with an antiendothelial antibody were quantified using an image analysis system. The extent of angiogenesis was expressed as the ratio of the mean tubule length in the test wells over that in blank control wells.
RESULTS: Venous ulcer exudates significantly inhibited angiogenesis (mean (95 per cent confidence interval) 0.72 (0.48 to 0.96)) compared with acute wound fluids (2.48 (0.86 to 4.10)) (P < 0.002) and VEGF (1.47 (1.32 to 1.61)) (P = 0.01). Exudates from the five non-healing venous ulcers inhibited angiogenesis (0.31 (0.15 to 0.46)) significantly more than exudates from the five rapidly healing venous ulcers (0.93 (0.21 to 1.65)) (P = 0.03).
CONCLUSION: Fluid exudate from venous ulcers, in particular those that healed slowly, inhibited experimental angiogenesis in this study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027980     DOI: 10.1046/j.1365-2168.2002.02085.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

Review 1.  Therapeutic strategies for enhancing angiogenesis in wound healing.

Authors:  Austin P Veith; Kayla Henderson; Adrianne Spencer; Andrew D Sligar; Aaron B Baker
Journal:  Adv Drug Deliv Rev       Date:  2018-09-26       Impact factor: 15.470

2.  Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

Authors:  Liangli Zhao; Elaine S Marshall; Lloyd R Kelland; Bruce C Baguley
Journal:  Invest New Drugs       Date:  2007-01-03       Impact factor: 3.651

3.  Inappropriate angiogenic response as a novel mechanism of duodenal ulceration and impaired healing.

Authors:  Xiaoming Deng; Ximing Xiong; Tetyana Khomenko; Zsuzsanna Sandor; Klara Osapay; Ganna Tolstanova; Joseph Shiloach; Longchuan Chen; Judah Folkman; Sandor Szabo
Journal:  Dig Dis Sci       Date:  2011-07-07       Impact factor: 3.487

4.  Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects.

Authors:  K Dredge; J B Marriott; C D Macdonald; H-W Man; R Chen; G W Muller; D Stirling; A G Dalgleish
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

5.  A prospective clinical trial evaluating changes in the wound microenvironment in patients with chronic venous leg ulcers treated with a hypothermically stored amniotic membrane.

Authors:  John P McQuilling; Marissa J Carter; Judith A Fulton; Keyur Patel; Bryan Doner; Thomas E Serena; Katie C Mowry
Journal:  Int Wound J       Date:  2021-05-06       Impact factor: 3.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.